Alimera Sciences, a startup focused on ophthalmic drugs, has filled out its board of directors.

The members are: Mark Brooks, managing director at BA Venture Partners; Brian Halak, principal of Domain Associates; Steve Martin, CEO and partner of Hi Tech Partners; Terry McGuire, co-founder of Polaris Venture Partners; Dr. Calvin Roberts of Weill Medical College of Cornell University; and Phil Tracy of Intersouth Partners.

Alimera recently closed on $26.75 million in venture financing.